Since IL-4, IL-5, and IL-13 promote airway eosinophilia, mucus overproduction and bronchial hyper-responsiveness, it is likely that hBD-2 improves lung resistance indirectly by lowering those cytokines in the lung (52). The gene discussed is DEFB4B; the disease is Increased total eosinophil count.